Santomauro, DF,
Herrera, AMM,
Shadid, J,
Zheng, P,
Ashbaugh, C,
Pigott, DM,
Abbafati, C,
Adolph, C,
Amlag, JO,
Aravkin, AY,
Bang-Jensen, BL,
Idrisov, B,
Group Author (2021) , with
depressive and anxiety
disorders being leading contributors to this burden. The emergence of the COVID-19
КОГНИТИВНЫЕ НАРУШЕНИЯ, ТРЕВОГА И ДЕПРЕССИЯ У ПАЦИЕНТОВ С ХРОНИЧЕСКИМИ ЛИМФОПРОЛИФЕРАТИВНЫМИ ЗАБОЛЕВАНИЯМИТЕРЕГУЛОВА, Д.Р.,
АХМАДЕЕВА, Л.Р.,
БАКИРОВ, Б.А.,
TEREGULOVA, D.R.,
AKHMADEEVA, L.R.,
BAKIROV, B.A. (2021) COGNITIVE IMPAIRMENT, ANXIETY, AND
DEPRESSION IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISEASES
Nouwen, A.,
Deschenes, S.S.,
Balkhiyarova, Z.,
Albertorio-Diaz, J.R.,
Prokopenko, I.,
Schmitz, N. (2021) Background: The prevalence of
depression is higher among those with diabetes than in the general
and
depression among students and dentists (n=80). Herein,
we developed the "Method for treating negative
Introduction: Due to severe burden of
depressive disorders and a low rate of remission in patients